Humira to be Replaced by Biosimilars on April 1
Effective April 1, 2024, Humira is being replaced on the NRECA Medical Plan’s prescription drug list by two biosimilars, Adalimumab-adaz and Hyrimoz. Humira is used to treat inflammatory conditions such as rheumatoid and psoriatic arthritis and autoimmune diseases like Crohn’s[…]